What are Cytotoxic T Lymphocytes?
Cytotoxic T Lymphocytes (CTLs), also known as CD8+ T cells, are a subset of T lymphocytes that play a crucial role in the immune response by directly killing infected, cancerous, or otherwise dysfunctional cells. They are essential for the adaptive immune response and are characterized by the expression of the CD8 glycoprotein on their surface.
What are the Key Histological Features of Cytotoxic T Lymphocytes?
Histologically, CTLs are characterized by their relatively small size and dense nucleus, with a scant amount of cytoplasm. When activated, they exhibit an enlarged cytoplasm with prominent
Golgi apparatus and secretory vesicles. The presence of these granules is indicative of their cytotoxic activity. Additionally, CTLs can form
immune synapses with their target cells, which is a specialized junction that facilitates the directed release of cytotoxic molecules.
What is the Clinical Significance of Cytotoxic T Lymphocytes?
CTLs are a major focus in immunotherapy for cancer treatment. Strategies like
CAR T-cell therapy involve engineering patient's T cells to express chimeric antigen receptors that can more effectively target and kill cancer cells. Additionally, monitoring the activity and presence of CTLs can be critical in understanding the progression of infectious diseases and in the assessment of vaccine efficacy.